However, CRISPR-mediated knockout of CDKN1A (encoding p21) in lung cancer cells is not sufficient to render them susceptible to OSKM-mediated reprogramming to iPSCs, even when combined with a pan-caspase inhibitor that also partially rescues the observed phenotypes. Here, CDKN1A is linked to lung cancer.